Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity

被引:67
作者
Yang, YK
Chen, M
Lai, YM
Gantz, I
Georgeson, KE
Harmon, CM
机构
[1] Univ Alabama, Div Pediat Surg, Dept Surg, Birmingham, AL 35233 USA
[2] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
关键词
D O I
10.1074/jbc.M201343200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hypothalamic melanocortin-4 receptor (MC4R), a seven transmembrane G-protein-coupled receptor, plays an important role in the regulation of body weight. The synthetic melanocortin analog SHU9119 has been widely used to characterize the physiological role of MC4R in feeding behavior and energy homeostasis. Previous studies indicated that SHU9119 is an agonist at the melanocortin-1 receptor (MC1R) but an antagonist at the MC4R. However, the molecular basis of the interaction between hMC4R and SHU9119 has not been clearly defined. To gain insight into the molecular determinants of hMC4R in the selectivity of SHU9119 chimeras and mutants hMC1R and hMC4R were expressed in cell lines and pharmacologically analyzed. A region of receptor containing the third transmembrane of hMC4R was found to be required for selective SHU9119 antagonism. Further mutagenesis studies of this region of hMC4R demonstrated that the amino acid residue leucine 133 in the third transmembrane was critical for the selective antagonist activity of SHU9119. The single substitution of leucine 133 to methionine did not affect SHU9119 binding to hMC4R. However, this substitution did convert SHU9119 from an antagonist to an agonist. Conversely, exchange of Met(128) in hMC1R to Leu, the homologous residue 133 of hMC4R, displayed a reduction in SHU9119 binding affinity and potency. This report provides the details of the molecular recognition of SHU9119 antagonism at hMC4R and shows that amino acid Leu(133) of hMC4R plays a key role in melanocortin receptor subtype specificity.
引用
收藏
页码:20328 / 20335
页数:8
相关论文
共 27 条
[1]   Analogs of lactam derivatives of α-melanotropin with basic and acidic residues [J].
Bednarek, MA ;
MacNeil, T ;
Kalyani, RN ;
Tang, R ;
Van der Ploeg, LHT ;
Weinberg, DH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (01) :23-28
[2]   A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences [J].
Benoit, SC ;
Schwartz, MW ;
Lachey, JL ;
Hagan, MM ;
Rushing, PA ;
Blake, KA ;
Yagaloff, KA ;
Kurylko, G ;
Franco, L ;
Danhoo, W ;
Seeley, RJ .
JOURNAL OF NEUROSCIENCE, 2000, 20 (09) :3442-3448
[3]   Role of melanocortinergic neurons in feeding and the agouti obesity syndrome [J].
Fan, W ;
Boston, BA ;
Kesterson, RA ;
Hruby, VJ ;
Cone, RD .
NATURE, 1997, 385 (6612) :165-168
[4]   Identification and functional analysis of novel human melanocortin-4 receptor variants [J].
Gu, W ;
Tu, ZM ;
Kleyn, PW ;
Kissebah, A ;
Duprat, L ;
Lee, J ;
Chin, W ;
Maruti, S ;
Deng, NH ;
Fisher, SL ;
Franco, LS ;
Burn, P ;
Yagaloff, KA ;
Nathan, J ;
Heymsfield, S ;
Albu, J ;
Pi-Sunyer, FX ;
Allison, DB .
DIABETES, 1999, 48 (03) :635-639
[5]   Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions [J].
Haskell-Luevano, C ;
Lim, S ;
Yuan, W ;
Cone, RD ;
Hruby, VJ .
PEPTIDES, 2000, 21 (01) :49-57
[6]   Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis:: Identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants [J].
Haskell-Luevano, C ;
Cone, RD ;
Monck, EK ;
Wan, YP .
BIOCHEMISTRY, 2001, 40 (20) :6164-6179
[7]   Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors [J].
HaskellLuevano, C ;
Nikiforovich, G ;
Sharma, SD ;
Yang, YK ;
Dickinson, C ;
Hruby, VJ ;
Gantz, I .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1738-1748
[8]   Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans [J].
Hinney, A ;
Schmidt, A ;
Nottebom, K ;
Heibült, O ;
Becker, I ;
Ziegler, A ;
Gerber, G ;
Sina, M ;
Görg, T ;
Mayer, H ;
Siegfried, W ;
Fichter, M ;
Remschmidt, H ;
Hebebrand, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1483-1486
[9]   CYCLIC LACTAM ALPHA-MELANOTROPIN ANALOGS OF AC-NLE(4)-CYCLO[ASP(5),D-PHE(7),LYS(10)] ALPHA-MELANOCYTE-STIMULATING HORMONE-(4-10)-NH2 WITH BULKY AROMATIC-AMINO-ACIDS AT POSITION-7 SHOW HIGH ANTAGONIST POTENCY AND SELECTIVITY AT SPECIFIC MELANOCORTIN RECEPTORS [J].
HRUBY, VJ ;
LU, DS ;
SHARMA, SD ;
CASTRUCCI, AD ;
KESTERSON, RA ;
ALOBEIDI, FA ;
HADLEY, ME ;
CONE, RD .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (18) :3454-3461
[10]   Targeted disruption of the melanocortin-4 receptor results in obesity in mice [J].
Huszar, D ;
Lynch, CA ;
FairchildHuntress, V ;
Dunmore, JH ;
Fang, Q ;
Berkemeier, LR ;
Gu, W ;
Kesterson, RA ;
Boston, BA ;
Cone, RD ;
Smith, FJ ;
Campfield, LA ;
Burn, P ;
Lee, F .
CELL, 1997, 88 (01) :131-141